Literature DB >> 11313975

Identification of a novel transcriptional repressor element located in the first intron of the human BRCA1 gene.

T C Suen1, P E Goss.   

Abstract

Loss or lowered expression of BRCA1 in non-familial breast cancer has been shown in several recent studies. Understanding how BRCA1 expression is regulated should provide new insights into the role of BRCA1 in sporadic breast cancer. We have recently identified a critical 18-base pair (bp) DNA element within the minimal BRCA1 promoter whereupon the formation of a specific protein-DNA complex and transcription of BRCA1 is dependent. We now report a non tissue-specific transcriptional repressor activity, located more than 500 bp into the first intron of BRCA1. Progressive deletions from the 3'-end of intron 1 and reporter gene assays localized the repressor activity to an 83-bp region. Electrophoretic mobility shift assays with this 83 bp DNA and various sub-fragments of it showed binding of nuclear proteins to a 36 bp BstNI-BseRI fragment. Functional transcriptional repression by this 36 bp DNA could be conferred on a heterologous thymidine kinase promoter. Analysis of multiple reporter gene constructs containing the BRCA1 genomic region driving transcription in both directions suggests that the putative negative regulatory element functions to block transcription only in the BRCA1 direction, although the promoter is shared by the divergently transcribed NBR2 gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313975     DOI: 10.1038/sj.onc.1204078

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  DBC1 is over-expressed and associated with poor prognosis in colorectal cancer.

Authors:  Yongguo Zhang; Yong Gu; Sumei Sha; Xiangyun Kong; Hongwu Zhu; Bin Xu; Yijun Li; Kaichun Wu
Journal:  Int J Clin Oncol       Date:  2013-01-09       Impact factor: 3.402

Review 2.  A guide for functional analysis of BRCA1 variants of uncertain significance.

Authors:  Gaël A Millot; Marcelo A Carvalho; Sandrine M Caputo; Maaike P G Vreeswijk; Melissa A Brown; Michelle Webb; Etienne Rouleau; Susan L Neuhausen; Thomas v O Hansen; Alvaro Galli; Rita D Brandão; Marinus J Blok; Aneliya Velkova; Fergus J Couch; Alvaro N A Monteiro
Journal:  Hum Mutat       Date:  2012-07-16       Impact factor: 4.878

3.  BP1, an isoform of DLX4 homeoprotein, negatively regulates BRCA1 in sporadic breast cancer.

Authors:  Brian J Kluk; Yebo Fu; Trina A Formolo; Lei Zhang; Anne K Hindle; Yan-gao Man; Robert S Siegel; Patricia E Berg; Chuxia Deng; Timothy A McCaffrey; Sidney W Fu
Journal:  Int J Biol Sci       Date:  2010-09-10       Impact factor: 6.580

4.  Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation.

Authors:  M-H Lee; T Lahusen; R-H Wang; C Xiao; X Xu; Y-S Hwang; W-W He; Y Shi; C-X Deng
Journal:  Oncogene       Date:  2011-06-13       Impact factor: 8.756

Review 5.  PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease.

Authors:  Yongyan Song; Shujin Li; Chuan He
Journal:  Front Cardiovasc Med       Date:  2022-03-23

Review 6.  Long Non-Coding RNA Neighbor of BRCA1 Gene 2: A Crucial Regulator in Cancer Biology.

Authors:  Ting Wang; Zhaosheng Li; Liujia Yan; Feng Yan; Han Shen; Xinyu Tian
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

Review 7.  The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer.

Authors:  Marcia L McCoy; Christopher R Mueller; Calvin D Roskelley
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

Review 8.  Regulation of BRCA1 expression and its relationship to sporadic breast cancer.

Authors:  Christopher R Mueller; Calvin D Roskelley
Journal:  Breast Cancer Res       Date:  2002-11-13       Impact factor: 6.466

Review 9.  Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition.

Authors:  Elizabeth Santana Dos Santos; François Lallemand; Leslie Burke; Dominique Stoppa-Lyonnet; Melissa Brown; Sandrine M Caputo; Etienne Rouleau
Journal:  Cancers (Basel)       Date:  2018-11-16       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.